Welcome to LookChem.com Sign In|Join Free

CAS

  • or

89399-20-2

Post Buying Request

89399-20-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89399-20-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 89399-20-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,3,9 and 9 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 89399-20:
(7*8)+(6*9)+(5*3)+(4*9)+(3*9)+(2*2)+(1*0)=192
192 % 10 = 2
So 89399-20-2 is a valid CAS Registry Number.

89399-20-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-nitro-N-pentylbenzamide

1.2 Other means of identification

Product number -
Other names 4-nitro-benzoic acid pentylamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:89399-20-2 SDS

89399-20-2Downstream Products

89399-20-2Relevant articles and documents

Nickel-catalyzed reductive amidation of aryl-triazine ethers

Heravi, Majid M.,Panahi, Farhad,Iranpoor, Nasser

supporting information, p. 1992 - 1995 (2020/02/22)

The reaction of activated phenolic compounds, 2,4,6-triaryloxy-1,3,5-triazine (aryl-triazine ethers), with various isocyanates or carbodiimides in the presence of a nickel pre-catalyst resulted in the synthesis of aryl amides in good to excellent yields.

Aminobenzamide compounds for the treatment of neurodegenerative disorders

-

, (2008/06/13)

A group of benzamide compounds are disclosed which are useful for treating neurodegenerative disorders. Methods for making these compounds are provided. These materials are formed into pharmaceutical compositions for oral or intravenous administration to patients suffering from conditions such as Parkinson's disease which can exhibit themselves as progressive loss of central nervous system function. The compounds can arrest or slow the progressive loss of function.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 89399-20-2